Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses via its partnership with the University of Oxford, raised a further £250 million ($300 million) in funding.
The fundraise involved a diverse group of international investors, with participation from existing and new blue-chip investors, sovereign wealth funds, family offices, pension funds and asset managers. This brings the total amount raised by OSE to more than £850 million (>$1 billion) since inception in 2015.
These funds enable the company to identify further science from the University of Oxford, providing initial funding, hands-on support and access to expert networks and start-up infrastructure, to create new spinouts across Life Sciences, Health Tech and Deep Tech.
In addition, OSE will continue to support its existing and maturing portfolio, deploying large amounts of capital in later-stage funding rounds.
In addition to funding, OSE provides strategic business-building and operational support to its portfolio companies, including access to a global network of entrepreneurs and advisers, and has added over 55,000 sq ft of lab and start-up space.
Founded in 2015 and led by Alexis Dormandy, Chief Executive Officer, OSE has invested in over 80 companies built on Oxford science, committing £0.5 billion itself and attracting over £1 billion from blue-chip, global co-investors. To date OSE has helped progress 27 companies from seed to Series A and 21 to Series B and beyond, including 2 IPOs and 5 trade exits.
FinSMEs
18/07/2022